301408 华人健康
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,420,98412.17%5,486,6844,531,6923,797,1603,262,425
减:营业总成本1,306,49411.17%5,115,0714,323,5893,656,9773,052,316
    其中:营业成本921,6659.53%3,626,9963,053,5942,633,7312,199,674
               财务费用7,44565.97%27,06824,69419,35022,702
               资产减值损失(5,376)-36.61%(79,737)(27,488)(6,864)(4,186)
公允价值变动收益0------340
投资收益54856.98%5,0261,619770811
    其中:对联营企业和合营企业的投资收益0--01831580
营业利润111,77232.46%300,183207,925152,723212,724
利润总额110,79032.59%294,391205,471151,508214,743
减:所得税费用24,70633.74%80,52453,21233,82654,485
净利润86,08432.27%213,867152,259117,682160,258
减:非控股权益6,74074.54%22,51414,5603,015(518)
股东净利润79,34429.60%191,353137,700114,668160,776

市场价值指针
每股收益 (元) *0.19829.59%0.4800.3400.2900.470
每股派息 (元) *----0.1000.1000.100--
每股净资产 (元) *5.4415.31%5.2425.0134.8592.786
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容